The Australian Pharmaceutical Subsidy Gambit: Transmuting Deadweight Loss and Oligopoly Rents to Consumer Surplus
收藏NBER1991-07-01 更新2025-01-04 收录
下载链接：
https://www.nber.org/papers/w3783
下载链接
链接失效反馈官方服务：
资源简介：
Australia pays less than other developed nations for her pharmaceuticals, about 45% as much as the United States. She achieves this result with an ingenious price-contingent subsidy scheme, which turns deadweight loss (due to pricing above marginal cost) into consumer surplus. Pharmaceutical
提供机构：
美国国家经济研究局
创建时间：
1991-07-01
